444 Alaska Avenue
Suite #BAA205 Torrance, CA 90503 USA
+1 424 999 9627
24/7 Customer Support
sales@markwideresearch.com
Email us at
Interventional Oncology Market – Size, Share, Trends, Analysis & Forecast 2026–2035
Interventional Oncology Market – Size, Share, Trends, Analysis & Forecast 2026–2035
Published Date: January, 2026
Base Year: 2025
Delivery Format: PDF+Excel, PPT
Historical Year: 2018-2024
No of Pages: 263
Forecast Year: 2026-2035
Corporate User License
Unlimited User Access, Post-Sale Support, Free Updates, Reports in English & Major Languages, and more
$3450
Interventional oncology is a rapidly growing field within the broader discipline of oncology that deals with the use of minimally invasive, image-guided procedures to diagnose and treat cancer. These procedures are performed using a variety of techniques, including ablation, embolization, and radiation therapy, and are often used in conjunction with traditional cancer treatments such as chemotherapy and surgery.
The global interventional oncology market is expected to grow at a compound annual growth rate (CAGR) of 8.9% from 2021 to 2028. This growth can be attributed to a number of factors, including an increasing incidence of cancer, a growing demand for minimally invasive procedures, and technological advancements in interventional oncology.
In this article, we will provide a detailed analysis of the interventional oncology market, including its meaning, key market insights, market analysis, market drivers, market restraints, market opportunities, market dynamics, regional analysis, competitive landscape, segmentation, category-wise insights, key benefits for industry participants and stakeholders, SWOT analysis, market key trends, Covid-19 impact, key industry developments, analyst suggestions, future outlook, and conclusion.
Interventional oncology is a medical specialty that focuses on the use of minimally invasive, image-guided procedures to diagnose and treat cancer. These procedures are performed using a variety of techniques, including ablation, embolization, and radiation therapy, and are often used in conjunction with traditional cancer treatments such as chemotherapy and surgery.
Interventional oncology procedures are typically performed by interventional radiologists or interventional oncologists, who use imaging technology such as X-rays, CT scans, and MRI scans to guide their procedures. These procedures can be performed on both primary and metastatic tumors, and can be used to treat a wide range of cancers, including liver, lung, kidney, and bone cancers.
Executive Summary
The global interventional oncology market is expected to grow at a CAGR of 8.9% from 2021 to 2028. This growth can be attributed to a number of factors, including an increasing incidence of cancer, a growing demand for minimally invasive procedures, and technological advancements in interventional oncology.
The market is characterized by a high degree of competition, with a large number of players operating in the space. Key players include Medtronic, Boston Scientific, Terumo Corporation, BTG plc, and Cook Medical.
The market is segmented by procedure type, including ablation, embolization, and radiation therapy. The ablation segment is expected to hold the largest share of the market due to its effectiveness and increasing adoption by healthcare providers.
North America is expected to hold the largest share of the market due to a high incidence of cancer and a growing demand for minimally invasive procedures. Asia Pacific is expected to grow at the highest CAGR during the forecast period due to an increasing incidence of cancer and improving healthcare infrastructure.
Important Note: The companies listed in the image above are for reference only. The final study will cover 18–20 key players in this market, and the list can be adjusted based on our client’s requirements.
Key Market Insights
The interventional oncology market is driven by a number of factors, including an increasing incidence of cancer, a growing demand for minimally invasive procedures, and technological advancements in interventional oncology.
According to the American Cancer Society, an estimated 1.8 million new cancer cases will be diagnosed in the United States in 2022. This increasing incidence of cancer is driving demand for new and innovative cancer treatments, including interventional oncology procedures.
In addition, there is a growing demand for minimally invasive procedures among patients and healthcare providers. These procedures offer a number of benefits over traditional cancer treatments, including faster recovery times, reduced pain and scarring, and lower rates of complications.
Finally, technological advancements in interventional oncology are driving growth in the market. For example, the development of new ablation techniques such as microwave ablation and irreversible electroporation (IRE) are increasing the effectiveness of these procedures and expanding their use to treat previously untreatable tumors.
Market Analysis
The global interventional oncology market is expected to grow at a CAGR of 8.9% from 2021 to 2028. The market is characterized by a high degree of competition, with a large number of players operating in the space. Key players include Medtronic, Boston Scientific, Terumo Corporation, BTG plc, and Cook Medical.
The market is segmented by procedure type, including ablation, embolization, and radiation therapy. The ablation segment is expected to hold the largest share of the market due to its effectiveness and increasing adoption by healthcare providers. The embolization segment is also expected to grow at a significant rate due to its ability to deliver targeted chemotherapy directly to the tumor site.
North America is expected to hold the largest share of the market due to a high incidence of cancer and a growing demand for minimally invasive procedures. Asia Pacific is expected to grow at the highest CAGR during the forecast period due to an increasing incidence of cancer and improving healthcare infrastructure.
Market Drivers
The interventional oncology market is driven by a number of factors, including:
- Increasing incidence of cancer: The growing prevalence of cancer is driving demand for new and innovative cancer treatments, including interventional oncology procedures.
- Growing demand for minimally invasive procedures: There is a growing demand among patients and healthcare providers for minimally invasive procedures, which offer a number of benefits over traditional cancer treatments.
- Technological advancements in interventional oncology: The development of new ablation techniques such as microwave ablation and irreversible electroporation (IRE) is increasing the effectiveness of these procedures and expanding their use to treat previously untreatable tumors.
Market Restraints
Despite the growth potential of the interventional oncology market, there are also a number of factors that could restrain its growth, including:
- High cost of procedures: Interventional oncology procedures can be expensive, which may limit their adoption in certain markets.
- Limited availability of trained specialists: Interventional oncology procedures require specialized training, which may limit their availability in certain regions.
- Regulatory hurdles: Regulatory hurdles and approval processes can be lengthy and expensive, which may limit the development and adoption of new interventional oncology procedures.
Market Opportunities
There are also a number of opportunities for growth in the interventional oncology market, including:
- Expansion into new markets: As healthcare infrastructure improves in emerging markets, there is a growing opportunity for interventional oncology procedures to be adopted in these regions.
- Development of new procedures and techniques: Continued investment in research and development could lead to the development of new interventional oncology procedures and techniques that are more effective and less invasive than current options.
- Collaboration with other healthcare providers: Collaboration between interventional oncologists and other healthcare providers, such as medical oncologists and radiation oncologists, could lead to more integrated and effective cancer treatments.
Market Dynamics
The interventional oncology market is a dynamic and rapidly evolving space. Factors such as the increasing incidence of cancer, growing demand for minimally invasive procedures, and technological advancements are driving growth in the market.
However, the market also faces challenges such as high costs, limited availability of trained specialists, and regulatory hurdles. These challenges must be addressed in order to fully capitalize on the opportunities for growth in the market.
Regional Analysis
North America is expected to hold the largest share of the interventional oncology market due to a high incidence of cancer and a growing demand for minimally invasive procedures. The market in the region is characterized by a high degree of competition, with a large number of players operating in the space. Key players in North America include Medtronic, Boston Scientific, and BTG plc.
Asia Pacific is expected to grow at the highest CAGR during the forecast period due to an increasing incidence of cancer and improving healthcare infrastructure. China and India are expected to be the key growth markets in the region, with rising healthcare expenditure and increasing demand for advanced cancer treatments.
Europe is also expected to hold a significant share of the market due to a high prevalence of cancer in the region. Key players in Europe include Terumo Corporation, BTG plc, and Medtronic.
Competitive Landscape
Leading companies in the Interventional Oncology Market:
- Medtronic plc
- Boston Scientific Corporation
- Merit Medical Systems, Inc.
- AngioDynamics, Inc.
- Terumo Corporation
- Cook Medical LLC
- BTG International Ltd. (Boston Scientific)
- HealthTronics, Inc. (Endo Health Solutions Inc.)
- MedWaves, Inc.
- Galil Medical Ltd. (BTG International Ltd.)
Please note: This is a preliminary list; the final study will feature 18–20 leading companies in this market. The selection of companies in the final report can be customized based on our client’s specific requirements.
Segmentation
The interventional oncology market is segmented by procedure type, including ablation, embolization, and radiation therapy. The ablation segment is expected to hold the largest share of the market due to its effectiveness and increasing adoption by healthcare providers.
The embolization segment is also expected to grow at a significant rate due to its ability to deliver targeted chemotherapy directly to the tumor site. The radiation therapy segment is expected to hold a smaller share of the market due to its invasive nature and potential side effects.
Category-wise Insights
The interventional oncology market can also be analyzed based on categories such as product type, cancer type, and end-user.
Product type categories include devices and accessories, while cancer type categories include liver cancer, lung cancer, kidney cancer, bone cancer, and others. End-user categories include hospitals, ambulatory surgical centers, and specialty clinics.
Key Benefits for Industry Participants and Stakeholders
Industry participants and stakeholders in the interventional oncology market can benefit from a number of factors, including:
- Growing demand for minimally invasive procedures: The increasing demand for minimally invasive procedures is driving growth in the market, providing new opportunities for industry participants.
- Technological advancements: Technological advancements in interventional oncology are expanding the range of procedures that can be performed, providing new opportunities for innovation.
- Increasing incidence of cancer: The growing prevalence of cancer is driving demand for new and innovative cancer treatments, including interventional oncology procedures.
SWOT Analysis
A SWOT analysis of the interventional oncology market can provide insights into the market’s strengths, weaknesses, opportunities, and threats.
Strengths:
- Growing demand for minimally invasive procedures
- Technological advancements in interventional oncology
- Increasing incidence of cancer
Weaknesses:
- High cost of procedures
- Limited availability of trained specialists
- Regulatory hurdles
Opportunities:
- Expansion into new markets
- Development of new procedures and techniques
- Collaboration with other healthcare providers
Threats:
- Competition from alternative cancer treatments
- Economic and political instability in key markets
- Unforeseen technological or regulatory developments
Market Key Trends
Some key trends shaping the interventional oncology market include:
- Technological advancements in ablation techniques: The development of new ablation techniques such as microwave ablation and irreversible electroporation (IRE) is increasing the effectiveness of these procedures and expanding their use to treat previously untreatable tumors.
- Expansion into new markets: As healthcare infrastructure improves in emerging markets, there is a growing opportunity for interventional oncology procedures to be adopted in these regions.
- Growing interest in combination therapies: Many healthcare providers are exploring the use of interventional oncology procedures in combination with traditional cancer treatments such as chemotherapy and surgery.
- Increasing adoption of embolization procedures: The ability of embolization procedures to deliver targeted chemotherapy directly to the tumor site is driving their adoption among healthcare providers.
- Investment in research and development: Continued investment in research and development is leading to the development of new interventional oncology procedures and techniques that are more effective and less invasive than current options.
Covid-19 Impact
The Covid-19 pandemic has had a significant impact on the interventional oncology market, with many procedures postponed or cancelled due to restrictions on elective surgeries and other medical procedures. However, the market has shown resilience, with many healthcare providers adopting telemedicine and other technologies to continue providing care to patients.
The pandemic has also highlighted the importance of minimally invasive procedures, as patients and healthcare providers look for options that minimize the risk of infection and reduce hospital stays. As a result, the market is expected to recover quickly as the pandemic subsides and demand for interventional oncology procedures returns.
Key Industry Developments
Recent key developments in the interventional oncology market include:
- Launch of new products and procedures: Key players in the market are continually launching new products and procedures, such as BTG plc’s TheraSphere Y-90 glass microspheres and Boston Scientific’s Embozene TANDEM microspheres.
- Acquisitions and partnerships: Key players are also partnering with or acquiring other companies to expand their presence in the market, such as Medtronic’s acquisition of RIST Neurovascular.
- Investment in research and development: Many companies are investing in research and development to develop new interventional oncology procedures and techniques that are more effective and less invasive than current options.
Analyst Suggestions
Analysts suggest that industry participants in the interventional oncology market should focus on innovation and product development to stay competitive. Key strategies include partnering with other healthcare providers, investing in research and development, and expanding into new markets.
Future Outlook
The interventional oncology market is expected to continue growing at a significant rate in the coming years, driven by factors such as the increasing incidence of cancer, growing demand for minimally invasive procedures, and technological advancements in interventional oncology. Key players in the market are expected to continue investing in research and development and expanding their presence in emerging markets.
Conclusion
The interventional oncology market is a dynamic and rapidly evolving space that is expected to continue growing at a significant rate in the coming years. Key drivers of growth include the increasing incidence of cancer, growing demand for minimally invasive procedures, and technological advancements in interventional oncology. Industry participants can benefit from these trends by focusing on innovation and product development, expanding into new markets, and collaborating with other healthcare providers. Despite challenges such as high costs and limited availability of trained specialists, the future outlook for the interventional oncology market is bright, with continued growth expected in the years to come.
What is interventional oncology?
Interventional oncology refers to a subspecialty of oncology that utilizes minimally invasive techniques to diagnose and treat cancer. This includes procedures such as ablation, embolization, and image-guided biopsies, which aim to target tumors while minimizing damage to surrounding healthy tissue.
Who are the key players in the interventional oncology market?
Key players in the interventional oncology market include companies like Medtronic, Boston Scientific, and Varian Medical Systems, which develop innovative technologies and devices for cancer treatment, among others.
What are the main drivers of growth in the interventional oncology market?
The growth of the interventional oncology market is driven by factors such as the increasing prevalence of cancer, advancements in imaging technologies, and the rising demand for minimally invasive procedures that offer quicker recovery times and reduced hospital stays.
What challenges does the interventional oncology market face?
Challenges in the interventional oncology market include the high cost of advanced technologies, the need for skilled professionals to perform complex procedures, and regulatory hurdles that can delay the introduction of new treatments.
What opportunities exist in the interventional oncology market?
Opportunities in the interventional oncology market include the development of new therapies and techniques, expansion into emerging markets, and the integration of artificial intelligence and machine learning to enhance treatment planning and outcomes.
What trends are shaping the interventional oncology market?
Trends in the interventional oncology market include the increasing use of personalized medicine, the rise of combination therapies that integrate interventional techniques with systemic treatments, and the growing focus on patient-centered care that emphasizes quality of life and treatment efficacy.
Interventional Oncology Market
| Segmentation | Details |
|---|---|
| Procedure Type | Radiofrequency Ablation, Embolization, Cryoablation, Microwave Ablation, Others |
| Product Type | Radiofrequency Ablation Devices, Embolization Devices, Cryoablation Devices, Microwave Ablation Devices, Others |
| Cancer Type | Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Others |
| End-User | Hospitals, Ambulatory Surgical Centers, Cancer Research Institutes |
| Region | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Please note: The segmentation can be entirely customized to align with our client’s needs.
Leading companies in the Interventional Oncology Market:
- Medtronic plc
- Boston Scientific Corporation
- Merit Medical Systems, Inc.
- AngioDynamics, Inc.
- Terumo Corporation
- Cook Medical LLC
- BTG International Ltd. (Boston Scientific)
- HealthTronics, Inc. (Endo Health Solutions Inc.)
- MedWaves, Inc.
- Galil Medical Ltd. (BTG International Ltd.)
Please note: This is a preliminary list; the final study will feature 18–20 leading companies in this market. The selection of companies in the final report can be customized based on our client’s specific requirements.
North America
o US
o Canada
o Mexico
Europe
o Germany
o Italy
o France
o UK
o Spain
o Denmark
o Sweden
o Austria
o Belgium
o Finland
o Turkey
o Poland
o Russia
o Greece
o Switzerland
o Netherlands
o Norway
o Portugal
o Rest of Europe
Asia Pacific
o China
o Japan
o India
o South Korea
o Indonesia
o Malaysia
o Kazakhstan
o Taiwan
o Vietnam
o Thailand
o Philippines
o Singapore
o Australia
o New Zealand
o Rest of Asia Pacific
South America
o Brazil
o Argentina
o Colombia
o Chile
o Peru
o Rest of South America
The Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Israel
o Kuwait
o Oman
o North Africa
o West Africa
o Rest of MEA
What This Study Covers
- ✔ Which are the key companies currently operating in the market?
- ✔ Which company currently holds the largest share of the market?
- ✔ What are the major factors driving market growth?
- ✔ What challenges and restraints are limiting the market?
- ✔ What opportunities are available for existing players and new entrants?
- ✔ What are the latest trends and innovations shaping the market?
- ✔ What is the current market size and what are the projected growth rates?
- ✔ How is the market segmented, and what are the growth prospects of each segment?
- ✔ Which regions are leading the market, and which are expected to grow fastest?
- ✔ What is the forecast outlook of the market over the next few years?
- ✔ How is customer demand evolving within the market?
- ✔ What role do technological advancements and product innovations play in this industry?
- ✔ What strategic initiatives are key players adopting to stay competitive?
- ✔ How has the competitive landscape evolved in recent years?
- ✔ What are the critical success factors for companies to sustain in this market?
Why Choose MWR ?
Trusted by Global Leaders
Fortune 500 companies, SMEs, and top institutions rely on MWR’s insights to make informed decisions and drive growth.
ISO & IAF Certified
Our certifications reflect a commitment to accuracy, reliability, and high-quality market intelligence trusted worldwide.
Customized Insights
Every report is tailored to your business, offering actionable recommendations to boost growth and competitiveness.
Multi-Language Support
Final reports are delivered in English and major global languages including French, German, Spanish, Italian, Portuguese, Chinese, Japanese, Korean, Arabic, Russian, and more.
Unlimited User Access
Corporate License offers unrestricted access for your entire organization at no extra cost.
Free Company Inclusion
We add 3–4 extra companies of your choice for more relevant competitive analysis — free of charge.
Post-Sale Assistance
Dedicated account managers provide unlimited support, handling queries and customization even after delivery.
Client Associated with us
QUICK connect
GET A FREE SAMPLE REPORT
This free sample study provides a complete overview of the report, including executive summary, market segments, competitive analysis, country level analysis and more.
ISO AND IAF CERTIFIED
Client Testimonials
GET A FREE SAMPLE REPORT
This free sample study provides a complete overview of the report, including executive summary, market segments, competitive analysis, country level analysis and more.
ISO AND IAF CERTIFIED